• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Forum Topics Started

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Aug 19
8:00 am - 9:00 am EDT

Member Forum: Equitable Access to Care

Aug 19
6:00 pm - 7:00 pm EDT

Member Forum: Equitable Access to Care

Aug 20
11:00 am - 12:00 pm EDT

ALS-FTD Clinicopathological Overlap

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy

View Calendar

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Lee Millard, England

    Lee Millard, England

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • John Sweeney, USA

    John Sweeney, USA

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • David Watson, Scotland

    David Watson, Scotland

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Mark Miller, UK

    Mark Miller, UK

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Greg Heydet, USA

    Greg Heydet, USA

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Lombana, Spain

    Lombana, Spain

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Frank Taylor, USA

    Frank Taylor, USA

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Willi Klein, UK

    Willi Klein, UK

  • Phil Rossall, UK

    Phil Rossall, UK

  • Mike Small, UK

    Mike Small, UK

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Hollister

    Hollister
    hollister

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Rosie Riley, USA

    Rosie Riley, USA

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Jean Waters, UK

    Jean Waters, UK

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login